Embleema (RWE) - ICO Details

  • RWE - Embleema ICO details,price, stage, bonus, team.
Embleema (RWE) Initial Coin Offering Logo
HeadlineEmpowering Patients to Own Their Health Data
CategoryDrugs & Healthcare
Starting date10/10/2019
Ending date01/01/2020
WebsiteView Website
WhitepaperView Whitepaper

Embleema ICO Summary

Embleema is bringing blockchain solution in the Drugs & Healthcare industry.

Their initial coin offering will be held from October 10, 2019 and investors will be able to buy it until January 1, 2020.

A total of 500,000,000 RWE will be created and 150,000,000 will be available during the coin offering.

RWE sale will be considered successful if their softcap of 2,000,000(USD) is reached. Please keep in mind that the sale could end before January 1, 2020 if the hardcap of 30,000,000(USD) is reached.

During Embleema ICO, investors will be able to buy RWE at 0.2 USD per Coin/Token.

Get all the details about Embleema below and on Embleema Official ICO website

Embleema Project Info

Embleema’s blockchain network offers a novel way to put patients at the center of clinical research by letting them own their health data, disrupting the slow, costly, manual and opaque process by which low quality health data is currently collected by pharmaceutical companies through Contrat Research Organisation, to monitor the efficacy of new investigational drugs.

Connecting patients directly to medical research and incentivizing them to share their data with tokens, blockchain is the decentralized technology everyone was waiting for to move away from the current linear process of drug approvals, to a new iterative model where trustworthy digital health data is shared in real time between patients, life sciences and regulators.

The 21st Century Cures Act (2016) gave the FDA a mandate to accelerate approvals if more patient real world data was shared proactively by pharma. Embleema’s blockchain speeds up this process with patient buy-in, accelerating time to market new drugs.


Coin SymbolRWE
Total Coins500000000
Working Product?

Embleema ICO Details

RWE ICO Details
Geo RestrictionUnited States of America (USA)
Currency AcceptedBTC,ETH
Total Coins500,000,000
Coins for Sale150,000,000
Private-Sale/Pre-Mined CoinsUnknown
Coins SoldUnknown
Coin Price0.2 USD
Softcap Reached
Confirmed Exchange
Unsold Coins Goes to

Embleema Stage Details


Start date10/10/2019
End date01/01/2020
Token for sale150,000,000
Token Price0.2 USD

Embleema Team Info

Core Team

Dr. Vahan Simonyan

Chief Scientific Advisor, former R&D Director of Bioinformatics at the FDA

Pr. John Halamka, MD

CIO of Beth Israel, Pr. of Innovation at Harvard

Bernard Gilly, PhD

CEO of iBionext - Pixum -

Frédéric Duchesne, Pharm.D

CEO of Pierre Fabre Pharmaceuticals

Adel B. Al-Saleh

CEO T-Systems

Embleema Discussion

Please Login to join the discussion
Notify of
Featured ICOs
There are No Featured ICOs right now
Trend Surfers
Recently Viewed ICO

Filter Info ICL
Join our Newsletter


Don't miss out!

Get discounts on ICOs & Blockchain products + Receive the latest News, Updates & PR from ICL.